High Purity 99% Ciprofloxacin Hydrochloride CAS 86483-48-9
GMP ISO 4 Inquiries
86483-48-9
Pharmaceutical Grade
0%
Foil Bag, Box, Drum
2022-12-31
Minoxidil,Paracetamol,Diclofenac sodium,fenbendazole,Ivermectin
-
Product Description
-
Seller Information
-
Inquiry History
-
Description
Product Name Ciprofloxacin hydrochloride Synonyms Ciprofloxacin base HCL CAS 86483-48-9 CAS: Ciprofloxacin hydrochloride 86483-48-9 MF: - MW: - EINECS: - Product Categories: Agrochemical Intermediates;Intermediates & Fine Chemicals;Dyestuff Intermediates;Flavor & Fragrance Intermediates;Gatiflo, Tequin and Zymar;Pharmaceutical intermediates Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibacterial agent developed by Bayer AG (initially called BAY 12-8039). It is marketed worldwide (as the hydrochloride) under the brand names Avelox, Avalox, and Avelon for oral treatment. In most countries, the drug is also available in parenteral form for intravenous infusion. Moxifloxacin is also sold in an ophthalmic solution (eye drops) under the brand names Vigamox, and Moxeza for the treatment of conjunctivitis (pink eye). Its antibacterial spectrum includes enteric Gram-() rods (Escherichia coli, Proteus species, Klebsiella species), Haemophilus influenzae, atypical bacteria (Mycoplasma, Chlamydia, Legionella), and Streptococcus pneumoniae, and anaerobic bacteria. It differs from earlier antibacterials of the fluoroquinolone class such as levofloxacin and ciprofloxacin in having greater activity against Gram-positive bacteria and anaerobes. Because of its potent activity against the common respiratory pathogen Streptococcus pneumoniae, it is considered a "respiratory quinolone."
In the United States, moxifloxacin is licensed for the treatment of acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, community acquired pneumonia, complicated and uncomplicated skin and skin structure infections, and complicated intra-abdominal infections.[4] In the European Union, it is licensed for acute bacterial exacerbations of chronic bronchitis, non-severe community-acquired pneumonia, and acute bacterial sinusitis.
CertificatesBasic Info-
Product Name:
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrochloride (1:?)
Other Name:3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-,hydrochloride (1:?);3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-,hydrochloride
CAS No.:86483-48-9
Molecular Formula:C17H18FN3O3.xClH
InChIKeys:InChIKey=DIOIOSKKIYDRIQ-UHFFFAOYSA-N
Molecular Weight:367.8
Exact Mass:367.11
EC Number:1806241-263-5
UNII:0MP32MFP6C
NSC Number:620634
DSSTox ID:DTXSID1047788
HScode:29419000
Categories:
Characteristics-
PSA:
72.9
XLogP3:0.28 (non-ionized)
Melting Point:>300 °C
Water Solubility:In water, 30,000 mg/L at 20 deg C
Storage Conditions:Store in tight, light-resistant container as defined in the USP-NF. This material should be handled and stored per label instructions to ensure product integrity.
Vapor Pressure:2.85X10-13 mm Hg at 25 deg C (est)
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Minoxidil,Paracetamol,Diclofenac sodium,fenbendazole,Ivermectin
-
Location:
I-City unit 3, South of Tangyan Road, Hi-Tech Industrial Zone, Xi'an City, Shaanxi Province, China
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
51-100
-
Year of Establishment:
2015
-
Certifications:
HACCP,Halal,GMP,ISO
"> -
-
Inquiry History4 Inquiries
Country Product Purchase Quantity Date Posted
Egypt
Ciprofloxacin Hydrochloride
50.00 KG Sep 20, 2023
India
Ciprofloxacin Hydrochloride
1 KG Jun 27, 2024
Pakistan
CIPROFLOXACIN HCL
50 KG Feb 1, 2024
Tunisia
Ciprofloxacin hydrochloride
300 KG Dec 19, 2023 Post an enquiry for this product